BroadOak Capital Partners
Bethesda, Marylandbroadoak.com
Overview
BroadOak Capital Partners is a life sciences focused, boutique financial institution that provides direct investment through BroadOak Asset Management, and investment banking services through BroadOak Partners, to companies in the life sciences tools, diagnostics, and biopharma services sectors. BroadOak has made investments in more than 70 companies and advised on over 50 successful M&A transactions.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| LabVoice Inc. | Jun 2026 | Seed Round | Co-investor |
| Quartzy | Apr 2026 | Debt | Lead |
| Axol Bioscience | Jan 2026 | Early Funding | Lead |
| Codis | Oct 2025 | Growth Equity | Co-investor |
| Precision Cell Systems | Sep 2025 | Corporate Funding | Lead |
Key People
Bill Snider
Partner
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
